Loading...
XETR
GXI
Market cap1.15bUSD
Jul 10, Last price  
28.48EUR
1D
-2.06%
1Q
66.84%
Jan 2017
-59.67%
IPO
-25.83%
Name

Gerresheimer AG

Chart & Performance

D1W1MN
XETR:GXI chart
P/E
P/S
0.42
EPS
Div Yield, %
0.14%
Shrs. gr., 5y
1.93%
Rev. gr., 5y
10.34%
Revenues
2.32b
+14.00%
646,691,000957,700,0001,060,103,0001,000,227,0001,024,804,0001,094,681,0001,219,068,0001,265,931,0001,290,016,0001,377,232,0001,375,460,0001,348,255,0001,367,730,0001,392,255,0001,418,786,0001,498,007,0001,817,094,0001,990,486,0002,035,903,0002,320,885,000
Net income
-320m
L
-26,940,000837,0004,510,0006,962,00046,747,00050,500,00060,191,00062,155,00066,336,000104,217,000121,638,000100,887,000128,965,00080,781,00088,559,00083,788,00096,120,000116,126,000109,720,000-320,316,000
CFO
210m
-12.82%
54,747,00054,108,000165,333,000117,466,000159,787,000129,747,000173,566,000146,676,000158,286,000203,776,000173,487,000219,163,000173,472,000192,924,000222,194,000212,076,000221,941,000294,337,000240,332,000209,526,000
Dividend
Jun 06, 20250.04 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. This segment also produces various plastic containers and closures, such as PET bottles, eye droppers, nasal sprays, nebulizers, and applicators, suitable for solid, liquid, and ophthalmic preparations, in addition to bottles for nutritional supplements. Its Primary Packaging Glass division specializes in essential glass packaging for both pharmaceutical and cosmetic industries. Offerings include infusion, dropper, and syrup bottles, injection vials, ampoules, and cartridges. This division also provides miniature bottles and glass containers for liquid food, spices, and spirits, as well as sophisticated packaging for fragrances, deodorants, skincare, wellness items, and diverse beauty and pharmaceutical products. The Advanced Technologies division is dedicated to pioneering smart drug delivery systems. A notable innovation is its micro-pumps, which empower patients to self-administer medications for conditions like Parkinson's disease or heart failure, catering to pharmaceutical and biotech clients. Established in 1864, the company's corporate headquarters are located in Düsseldorf, Germany.
IPO date
Jun 11, 2007
Employees
11,234
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑112024‑112023‑112022‑112021‑112020‑112019‑112018‑112017‑112016‑11
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT